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The characteristics of HIV/AIDS patients with
deep vein thrombosis at Dr George Mukhari
Academic Hospital
I. Govender
Medunsa, Pretoria, South Africa
Background: Deep vein thrombosis (DVT) is ten times more
prevalent in HIV/AIDS patients than the general population.
HIV/AIDS has also been shown to be a hypercoagulable state which
is worsened by conditions like malignancies, opportunistic infec-
tions, some auto-immune diseases and chemotherapeutic agents.
Methods & Materials: This was a cross sectional, descriptive
study looking at all HIV/AIDS patients admitted to level one wards
at the hospital without DVT.
Results: Variable Frequency Percent
On HAART 6 35%
On Tuberculosis treatment 8 47%
Improvement of DVT 16 94%
Pneumonia excluding Tuberculosis 4 24%
Discharged on warfarin 17 100%
Attempted suicide 2 12%
Cerebro vascular accident 1 6%
Gastroenteritis 4 24%
Anaemia – recorded 2 12%
Mean duration of admission 14.1 days
Conclusion: Patients with HIV/AIDS and opportunistic infec-
tions, or other predisposing factors such as immobility are more
likely to develop DVTs.
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The proﬁles of HIV-infected patients treated at
A. Wahab Sjahranie General Hospital
Samarinda, Indonesia
C. Gunawan
A. Wahab Sjahranie General Hospital, Samarinda,
Indonesia
Background: The number of HIV-infected patients and deaths-
related to HIV are increasing rapidly in Indonesia. Studies about
the proﬁles of HIV-infected patients can be useful to create better
approaches for prevention and treatment.
The aimof this studywas to evaluate the proﬁles ofHIV-infected
patientswho got ARV treatment in VCT clinic at A.Wahab Sjahranie
General Hospital Samarinda.
Methods & Materials: This study was conducted at A.
Wahab Sjahranie General Hospital in Samarinda, East Kalimantan,
Indonesia from December 2005 to September 2015. Subjects were
HIV-infected patients who got ARV treatment at VCT clinic.
Results: Until September 2015 there were 394 patients who
had taken ARV, 96 (24.4%) of them had died. Among 298 patients
who were on ARV treatment, there were 172 males (57.7%) and
126 females (42.3%) with ages distribution were as follow : ≤ 10
years 10 (3.4%), 11-20 years 11 (3.7%), 21-30 years 118 (39.6%), 31-
40 years 104 (34.9%), 41-50 years 36 (12.0%), > 50 years 19 (6.4%).
Routes of transmission were as follow : sexual 274 (91.9%), IDU 10
(3.4%), mother to child 10 (3.4%), others 4 (1.3%). CD4 levels when
starting ARV : < 50 : 107 (35.9%), 51-100 : 59 (19.8%), 101-200 : 69
(23.2%), 201-350 : 43 (14.4%), 351-500 : 14 (4.7%), > 500 : 6 (2.0%).
The most common ARV regimen used for adults was TDF-3TC-EFV
(71.8%). Patients who started taking ARV when pregnant were 19
(6.4%). Adherence to ARV : > 95% 227 (76.2%), 80-95% 23 (7.7%), <
80% 48 (16.1%).
Conclusion: The majority of patients who get ARV treatment at
VCT clinic of A. Wahab Sjahranie General Hospital Samarinda are
youngpeople (21-40yearsold), and themajor routeof transmission
is sexual intercourse. Most of the patients start taking ARV in a late
phase of infection which is correlated with poor prognosis.
http://dx.doi.org/10.1016/j.ijid.2016.02.582
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Metabolic syndrome among people living with
HIV (PLHIV)
G.R. Jammy1,∗, M. Dinaker2, P.S. Reddy3, C.H.
Bunker1
1 Graduate School of Public Health, University of
Pittsburgh, Pittsburgh, USA
2 GYD Reference Laboratory, Hyderabad, India
3 SHARE INDIA, MediCiti Institute of Medical
Sciences, Ghanpur, Hyderabad, India
Background: India ranks third in the world for number of peo-
ple living with HIV (PLHIV). Anti-Retroviral Therapy (ART) has
led to decline of morbidity and mortality, making HIV a chronic
manageable disease. This increased life span extends exposure
to environmental/lifestyle risk factors contributing cardiovascular
diseases (CVD) and other diseases of aging. Metabolic syndrome
(MS) is a clustering of risk factors for CVD, and an important pub-
lic health concern. Globally prevalence of MS among PLHIV varies
from 11 – 45%, but data are sparse on MS among PLHIV in India.
We describe the prevalence of MS among PLHIV population from
southern India.
Methods & Materials: A cross-sectional study with non-
probability consecutive sampling in a private clinic of Hyderabad
was carried out. Adult PLHIV under the care of the physician
consultant, with informed consent, were included in the study
irrespective of their ART status. Structured questionnaire, anthro-
pometric measurement and fasting blood samples were drawn.
Metabolic syndromewas deﬁned using International Diabetes Fed-
eration (IDF) and U.S. National Cholesterol Education Program
Adult Treatment Panel III (ATPIII) criteria, with speciﬁc cut offs
